Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brianna Sa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Dermatological Research|November 21, 2023
Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patientsLeore Lavin, Benjamin Ungar, Brianna Sa, et al.
Skin Appendage Disorders|October 8, 2025
Dermatologic Implications of Glucagon-Like Peptide-1 Receptor Agonist MedicationsOlivia M Burke, Brianna Sa, David Alvarez Cespedes, et al.
Dermatology and Therapy|February 16, 2026
Pediatric Psychodermatology: Advancing Therapy through Integrated CareBrianna Sa, Nicole Khalil, Elise Edwards, et al.
Journal of the American Academy of Dermatology|January 25, 2025
Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort studyOlivia Burke, Brianna Sa, David Alvarez Cespedes, et al.
Journal of the American Academy of Dermatology|April 27, 2025
Mapping melanoma mortality hot spots: A geographic spatial analysis of socioeconomic and provider disparitiesEli Kasheri, Brianna Sa, Garret Kraft, et al.
Experimental Dermatology|December 7, 2023
Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositisYusheng Zhang, Narges Maskan Bermudez, Brianna Sa, et al.
Diabetes, Obesity & Metabolism|October 23, 2025
Psychiatric effects of GLP-1 receptor agonists: A systematic review of emerging evidenceBrianna Sa, Anthony Maristany, Ashwin Subramaniam, et al.
Journal of Psychiatric Research|January 30, 2026
Retrospective chart review on psychiatric manifestations of GLP-1 agonist usageBrianna Sa, Anthony Maristany, Ashwin Subramaniam, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
Efficacy and Safety of Cysteamine-Isobionic Amide Complex in the Treatment of Periorbital HyperpigmentationKayla Zafar, Julia Stolyar, Alexia Collins, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Dermatological Research|November 21, 2023
Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patientsLeore Lavin, Benjamin Ungar, Brianna Sa, et al.
Skin Appendage Disorders|October 8, 2025
Dermatologic Implications of Glucagon-Like Peptide-1 Receptor Agonist MedicationsOlivia M Burke, Brianna Sa, David Alvarez Cespedes, et al.
Dermatology and Therapy|February 16, 2026
Pediatric Psychodermatology: Advancing Therapy through Integrated CareBrianna Sa, Nicole Khalil, Elise Edwards, et al.
Journal of the American Academy of Dermatology|January 25, 2025
Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort studyOlivia Burke, Brianna Sa, David Alvarez Cespedes, et al.
Journal of the American Academy of Dermatology|April 27, 2025
Mapping melanoma mortality hot spots: A geographic spatial analysis of socioeconomic and provider disparitiesEli Kasheri, Brianna Sa, Garret Kraft, et al.
Experimental Dermatology|December 7, 2023
Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositisYusheng Zhang, Narges Maskan Bermudez, Brianna Sa, et al.
Diabetes, Obesity & Metabolism|October 23, 2025
Psychiatric effects of GLP-1 receptor agonists: A systematic review of emerging evidenceBrianna Sa, Anthony Maristany, Ashwin Subramaniam, et al.
Journal of Psychiatric Research|January 30, 2026
Retrospective chart review on psychiatric manifestations of GLP-1 agonist usageBrianna Sa, Anthony Maristany, Ashwin Subramaniam, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
Efficacy and Safety of Cysteamine-Isobionic Amide Complex in the Treatment of Periorbital HyperpigmentationKayla Zafar, Julia Stolyar, Alexia Collins, et al.
Pageof 1